Matt Woll

Company: PTC Therapeutics

Job title: Vice President, Chemistry

Seminars:

Early Discovery Lessons Learned Along the Path to Risdiplam 9:30 am

With the discovery and commercial success of Evrysdi® (risdiplam) in treating SZA, the use of small molecules to influence pre-mRNA splicing has become a fertile ground for drug discovery With hindsight vision, some of the key determinants to successful identification of risdiplam precursors will be discussed, including the importance of a sensitive screening assay and…Read more

day: Day 1 AM